1. Gilardi GL, Hirschl S, Mandel M. Characteristics of yellow-pigmented nonfermentative bacilli (groups Ve-1 and Ve-2) encountered in clinical bacteriology. J Clin Mcrobiol 1975;1:384-9.
2. Kodama K, Kimura N, Komagata K. Two new species of Chryseomonas: C. oryzihabitans isolated from rice paddy and clinical specimens and C. luteola isolated from clinical specimens. Int J Syst Bacteriol 1985;35:467-74.
3. Kiska DL, Gilligan PH. Chryseomonas. In Murray PR, Baron EJO, Pfaller MA, Tenover FC, Yolken RH, editors, Manual of Clinical Microbiology, 7th Edition, Washington DC: American Society for Microbiology 1999:517-25.
4. Hogevik H, Olaison L, Andersson R, et al. Epidemiological aspects of infective endocarditis in urban population: A five year prospective study. Medicine
1995;74:324-39.
5. Sandre RM, Shafran SD.1996. Infective endocarditis: Review of 135 cases over 9
years. Clin Infect Dis 1996;22:276-86.
6. National Committee for Clinical Laboratory Standards (NCCLS). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved Standard M7-A5.Wayne PA. 2000.
7. Berger SA, Siegman-Igra Y, Stadler J, Campus A. Group VE-1 septicemia. J Clin
Microbiol 1983;17: 926-7.
8. Connor BJ, Kopecky RT, Frymoyer PA, Forbes BA. Recurrent Chryseomonas luteola (CDC Group Ve-1) peritonitis in a patient undergoing continuous ambulatory
peritoneal dialysis. J Clin Microbiol 1987;25:1113-4.
9. Engel JM, Alexander FS, Pachucki CT. Bacteremia caused by CDC group Ve-1 in previously healthy patient with granulomatous hepatitis. J Clin Microbiol 1987;25,
2023-4.
10. Freney J, Hansen W, Etienne J, Vandenesch F, Fleurette J. Postoperative infant septicemia caused by Chryseomonas luteola (CDC Group Ve-1) and Chryseomonas
oryzihabitans (CDC Group Ve-2). J Clin Microbiol 1988;26:1241-3.
11. Ghosh, SK. A rare infection caused by Chryseomonas luteola. J Infect 2000;41:109-10.
12. Hawkins RE, Moriarty RA, Lewis DE, Oldfield EC. Serious infections involving the CDC group Ve bacteria Chryseomonas luteola and Flavimonas oryzjhahitans. Rev Infect Dis
1991;13:257-60.
13. Kostman JR, Solomon F, Fekete T. Infection with Chryseomonas luteola (CDC group Ve-1) and Flavimonas oryzihabitans (CDC group Ve-2) in neurosurgical patients. Rev
Infect Dis 1991;13:233-36.
14. Rastogi, S, Sperber SJ. Facial cellulitis and Chryseomonas luteola bacteremia in an otherwise healthy patient. Diagn Microbiol Infect Dis 1998;32:303-5.
15. Tsakris A, Hassapopoulou H, Skoura HL, Pournarasc S, Douboyasc J. Leg ulcer due to Pseudomanas luteola in a patient with sickle cell Disease. Diag Microbiol Infect Dis
2002;42:141-3.
16. O'Leary T, Fong IW. Prosthetic valve endocarditis caused by Group Ve-1 bacteria. J
Clin Microbiol 1984;20:995.
17- Fass RJ, Barnishan J. In vitro susceptibilities of nonfermentative gram negative bacilli other than Chryseomonas aeruginosa to 32 antimicrobial agents. Rev Infect Dis
1980;2:841-53.
Thank you for copying data from http://www.arastirmax.com